Results 81 to 90 of about 2,436 (126)

Factors Associated with Low-Dose Tamoxifen Use among Women with Atypical Hyperplasia or Lobular or Ductal Carcinoma In Situ. [PDF]

Cancer Prev Res (Phila)
Deshmukh MS, Kyle MH, Zeiger PJ, Ro V, McGuinness JE, Michel A, Eli R, Kukafka R, Crew KD.   +8 more
europepmc   +1 more source

Trimethylamine N-oxide as a potential biomarker for predicting axillary lymph node metastasis in breast cancer: a retrospective study. [PDF]

World J Surg Oncol
Wu Z, Cheng Y, Lin S, Hu Q, Fu X, Li Z, Qin G, Li H.   +7 more
europepmc   +1 more source

SEPT9 methylation as a diagnostic and predictive biomarker in the progression of ductal carcinoma in situ to invasive breast cancer. [PDF]

Sci Rep
Guo Y, Zhou X, Xu H, Wang G.
europepmc   +1 more source

A case of breast cancer developed in the chronic expanding hematoma cyst wall. [PDF]

Radiol Case Rep
Sudo A, Oura S.
europepmc   +1 more source

Reoperation Versus Dose-Escalated Radiotherapy for Ductal Carcinoma <i>In Situ</i> at the Surgical Margin After Breast-Conserving Surgery for Invasive Ductal Carcinoma. [PDF]

J Breast Cancer
Park B, Choi S, Han J, Jung SY, Lee S, Kang HS, Kim S, Kwon Y, Lee EG.   +8 more
europepmc   +1 more source

Multimodal Imaging of Ductal Carcinoma In Situ: A Single-Center Study of 75 Cases. [PDF]

Med Sci (Basel)
Urraro F, Giordano N, Patanè V, Brunese MC, Varelli C, Russo C, Brunese L, Cappabianca S.   +7 more
europepmc   +1 more source

Role of ERβ in Triple-Negative Breast Cancer Associated with p53 and Androgen Receptor. [PDF]

Int J Mol Sci
Ito K, Honma N, Ogata H, Yamada A, Miyashita M, Arai T, Sasaki E, Shibuya K, Mikami T, Sawaki M.   +9 more
europepmc   +1 more source

Impact of screening on late-stage breast cancer in the Netherlands: a population-based cohort study (2007-2016). [PDF]

Breast
Lin Y, Sidorenkov G, Wang J, Greuter MJW, Houssami N, Dorrius MD, Siesling S, de Munck L, de Bock GH.   +8 more
europepmc   +1 more source